- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04406909
Rapid-Cycle Re-Implementation of TRAining Facilities in Norway (TRAiN)
This study tests the randomized re-opening of training facilities in Norway in relation to the COVID-19 pandemic. The investigators will use the recently developed concept of rapid-cycle randomized implementation to assure fast and safe re-introduction of training facilities by randomized testing of access restriction and measure virus exposure and immunity as well as clinical disease during the intervention to enable safe and timely downgrading of COVID-19 restrictions.
Members of training facilities in Norway age 18 to 64 years without COVID-19 related comorbidity will after informed consent be randomised to either access to training or no access in a first 2-week cycle. Testing for COVID-19 and ascertainment of clinical disease will be performed after the first cycle. If there is no clinically meaningful difference between the arms, new cycles may be implemented subsequently, e.g. with less distancing restrictions or wider age groups.
Studieöversikt
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Oslo, Norge, 0218
- SATS Training
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
all members of participating training facilities age 18 years or older who are not at increased risk for severe COVID-19 disease (see www.fhi.no for criteria) are eligible for participation if they
- plan to use the training facility regularly during the project period
- are willing to adhere to training policies during the project
- accept assessment of project endpoints
- approve handling of data for the project
Exclusion Criteria:
- COVId-19 related comorbidity
- Age below 18 years or above 64 years
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Training
Access to training at membership training facility
|
Access to training facility under national regulations for COVID control
|
Inget ingripande: No training
No access to training at membership training facility
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
COVID-19 RNA test positivity
Tidsram: At the end of Cycle 1 (cycle length is 14 days)
|
Percentage of COVID-19 RNA positive individuals
|
At the end of Cycle 1 (cycle length is 14 days)
|
Hospital admission for COVID-19
Tidsram: 7 days after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of people admitted to hospital for COVID-19
|
7 days after the end of Cycle 1 (cycle length is 14 days)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
individuals with COVID-19 antibodies
Tidsram: 14 to 20 days after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of individuals with COVID-19 antibodies by blood sampling
|
14 to 20 days after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of individuals with health care contacts
Tidsram: 7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of people who had any contacs with primary or secondary health care services
|
7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
Need of ventilator treatment after hospital admission for COVID-19
Tidsram: 7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of people in need of ventilator after hosital admission for COVID-19
|
7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
ICU admission for COVID-19
Tidsram: 7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of people admitted to the ICU for COVID-19
|
7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
Cause-specific death
Tidsram: 7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
Percentage of people who died, with cause of death (including underlying cause of death)
|
7 days and 3 months after the end of Cycle 1 (cycle length is 14 days)
|
COVID-19 RNA test positivity in employees at training centres
Tidsram: At the end of Cycle 1 (cycle length is 14 days)
|
Percentage of COVID-19 RNA positive employees who worked at the training centres during the intervention
|
At the end of Cycle 1 (cycle length is 14 days)
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Magnus Løberg, MD PhD, University of Oslo
- Huvudutredare: Mette Kalager, MD PhD, University of Oslo
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- REK 143984
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Träning
-
Riphah International UniversityRekryteringIntegrerad motståndsträning | Isolerad Resised TrainingPakistan
-
Autism SpeaksUniversity of California, Los Angeles; Vanderbilt University; Hugo W. Moser...AvslutadJoint Engagement + Enhanced Milieu Training | Joint Engagement + Enhanced Milieu Training + Augmentative Communication (AAC)Förenta staterna
-
Cardenal Herrera UniversityHar inte rekryterat ännuMotoriska bilder | Andningsfunktion | Action Observation Training
-
Methodist Health SystemAnmälan via inbjudanMock Code Training SimuleringFörenta staterna
-
University of ThessalyAvslutadKontrollera | Speed Endurance Training Protocol 1 | Speed Endurance Training Protocol 2Grekland
-
University of ThessalyAvslutadPower Training Exercise ProtocolsGrekland
-
Riphah International UniversityRekryteringPlanterfasciit | Excentrisk Heel Drop Training | 3-D fotledsrörlighetPakistan
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityHar inte rekryterat ännuAxiell förlängning | Ungdomar och barn | Naked Eye 3D Vision Training | Visuell funktion
-
Cairo UniversityHar inte rekryterat ännuDeep Neck Flexors Training | Post isometrisk avslappning
-
Inonu UniversityHar inte rekryterat ännuStroke | Motoriska bilder | Action Observation Training | Graderade motorbilderKalkon
Kliniska prövningar på Access to training facility
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Trial Unit, Center for Clinical Intervention Research; Center...AvslutadPatienter med extremt hög risk för psykosDanmark